XML 87 R73.htm IDEA: XBRL DOCUMENT v3.23.3
Investments in and Advances to Joint Ventures - Summary of Financial Information for Consolidated Joint Ventures (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Schedule Of Equity Method Investments [Line Items]          
Current assets $ 2,015,541   $ 2,015,541   $ 1,719,783
Total assets 4,732,988   4,732,988   4,198,142
Current liabilities 1,394,093   1,394,093   1,108,119
Total liabilities 2,484,888   2,484,888   2,102,207
Total joint venture equity 2,172,736   2,172,736   2,043,570
Revenue 1,418,571 $ 1,134,370 3,948,523 $ 3,092,160  
Costs 1,124,305 872,423 3,109,713 2,388,095  
Net income attributable to Parsons Corporation 47,447 29,571 116,241 68,533  
Net income attributable to noncontrolling interests 12,364 14,024 33,617 21,685  
Consolidated Joint Ventures          
Schedule Of Equity Method Investments [Line Items]          
Current assets 418,854   418,854   289,837
Noncurrent assets 11,637   11,637   9,961
Total assets 430,491   430,491   299,798
Current liabilities 278,168   278,168   194,701
Noncurrent liabilities 3,504   3,504   3,763
Total liabilities 281,672   281,672   198,464
Total joint venture equity 148,819   148,819   $ 101,334
Revenue 185,602 130,344 514,339 333,967  
Costs 160,423 101,882 445,829 289,485  
Net income attributable to Parsons Corporation 25,179 28,462 68,510 44,482  
Net income attributable to noncontrolling interests $ 12,364 $ 14,024 $ 33,617 $ 21,685